查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
臨床試驗管理服務的全球市場 - 產業規模，佔有率，趨勢，機會，預測:各服務形式，各業界，各適應症，各企業，各地區(2017年～2027年)
市場調查報告書
商品編碼
1166579

臨床試驗管理服務的全球市場 - 產業規模，佔有率，趨勢，機會，預測:各服務形式，各業界，各適應症，各企業，各地區(2017年～2027年)

Clinical Trials Management Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Service Type, By Industry, By Indication, By Company and By Region
出版日期: | 出版商: TechSci Research | 英文 113 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球臨床試驗管理服務市場，預計從2023年到2027年的預測期間內完成驚人的成長。

主要原因，包含各種疾病的發生率增加，個人化醫療的需求高漲，技術廣泛的開發，促進市場成長。支撐市場成長的其他的因素，是廣泛的研究開發，各種與生命相關疾病的盛行率，多數的臨床試驗研究調查，對疫苗接種與醫藥品的龐大需求，人口高齡化的發展，製藥公司和生物科技企業的研究開發活動的投資增加等。還有由於慢性疾病與其他的文明病增加，全球市場成長加速。

本報告提供全球臨床試驗管理服務市場相關調查，各市場區隔分析，市場動態，企業簡介等資訊。

目錄

第1章 服務類型概要

第2章 調查手法

第3章 摘要整理

第4章 COVID-19對全球臨床試驗管理服務市場的影響

第5章 VOC (客戶的迴響)

第6章 全球臨床試驗管理服務市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各服務形式(臨床試驗監測，核准申請，臨床試驗資料管理，設施管理、監測，其他)
    • 各業界(醫療設備 v/s 醫藥品)
    • 各適應症(免疫學，血液學，腫瘤學，神經學，其他)
    • 各地區
    • 各企業(2021年)
  • 市場地圖

第7章 北美的臨床試驗管理服務市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各服務形式
    • 各業界
    • 各適應症
    • 各國
  • 北美:各國分析
    • 美國
    • 加拿大
    • 墨西哥

第8章 歐洲的臨床試驗管理服務市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各服務形式
    • 各業界
    • 各適應症
    • 各國
  • 歐洲:各國分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第9章 亞太地區的臨床試驗管理服務市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各服務形式
    • 各業界
    • 各適應症
    • 各國
  • 亞太地區:各國分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第10章 南美的臨床試驗管理服務市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各服務形式
    • 各業界
    • 各適應症
    • 各國
  • 南美:各國分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章 中東、非洲的臨床試驗管理服務市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各服務形式
    • 各業界
    • 各適應症
    • 各國
  • 中東、非洲:各國分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢與發展

第14章 競爭情形

  • Laboratory Corporation of America Holdings
  • SGS Health Sciences
  • IQVIA, Inc.
  • Syneous Health, Inc.
  • Atlantic Research Group
  • ICON PLC
  • Charles River Laboratories International, Inc.
  • Medpace Holdings, Inc.

第15章 策略性建議

簡介目錄
Product Code: 12996

The global clinical trials management services market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of various diseases, upsurge demand for personalized medicines, and extensive development in technology, are curbing the market's growth. A clinical trial is a process in which several experiments or studies are performed on animals and humans to examine the results. Clinical trials are divided into two types that is observational studies and interventional trials. The other factors supporting the market's growth are, the extensive research and development, prevalence of various life-related diseases, large number of clinical trials and research studies, huge demand for vaccinations and medications, the growing aging population, and rise in investments by pharmaceutical and biotechnology companies in research and development activities.

Increasing Prevalence of Chronic and Lifestyle-Related Disorders

The growing occurrences of chronic diseases and other lifestyle-based diseases among population are augmenting the growth of the market, globally. Nowadays, people are opting for unhealthy choices such as tobacco, smoking, consumption of junk foods and others, due to which they suffer from various chronic diseases such as diabetes, heart strokes, hypertension, blood pressure and other. As per the national health survey, between 2017-2018, approximately 28.8% of adults in the UAE have high blood pressure. Owing to the increasing prevalence of these chronic diseases and growing demand for effective treatment methods, the surge in demand for development of innovative drugs is propelling the growth of the market, globally.

Rise in R&D Activities

Rising research and development activities for novel and personalized medications are propelling the growth of the market. Increasing investments in R&D activities such as by governments and key market players are strengthening the growth of the market. For instance, according to WHO, in 2020, 147,213 trials took place in the United States, then 23,051 trials in China and 13,481 in Japan.

Growing Demand for Precision Medicines

Growing prominence of specialized medicines is one of the primary factors, supporting the growth of the market. The surging demand for personalized medicines is due to their efficiency to treat unique, yet complex diseases. Doctors, researchers, and pharmaceutical firms are using precision medicine to develop new drugs and disease therapies, which surge the demand for clinical trial management services. For instance, in 2020, according to scope and significance of progress report, specialized medicines reported for about 39 percent of the total FDA-approved new drugs in the year.

Technological Advancements

Rapid advancements in tools and techniques are curbing the growth of the market. The increasing adoption of advanced technology such as AI, cloud based clinical trials, and machine learning in healthcare sector is driving the growth of the market. For instance, in South Korea, Asan Medical Center (AMC) has developed a new system, capable of handling clinical trial image data from group to extraction. This is expected to be a major revolution in CTM systems, as this could make clinical trials more effective and speedier than ever before. Similarly, as per the Veeva Unified Clinical Operations Survey, CROs are making major advancements to speed up and modernize clinical trials.

Market Segmentation

The global clinical trials management services market is segmented into service type, industry, indication, and company. Based on service type, the market is segmented into clinical trial monitoring, regulatory submissions, clinical trial data management, site management & monitoring, and others. Based on industry, the market is segmented into medical devices, and pharmaceuticals. Based on indication, the market is divided into immunology, hematology, oncology, neurology, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising occurrences in chronic diseases and extensive technology development in the country.

Market Players

Laboratory Corporation of America Holdings, SGS Health Sciences, IQVIA, Inc., Syneous Health, Inc., Atlantic Research Group, ICON PLC, Charles River Laboratories International, Inc., and Medpace Holdings, Inc. are some of the leading companies operating in the market.

Report Scope:

In this report, global clinical trials management services market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Clinical Trials Management Services Market, By Service Type:

Clinical Trial Monitoring

Regulatory Submissions

Clinical Trial Data Management

Site Management & Monitoring

Others

  • Clinical Trials Management Services Market, By Industry:

Medical Devices

Pharmaceuticals

  • Clinical Trials Management Services Market, By Indication:

Immunology

Hematology

Oncology

Neurology

Others

  • Clinical Trials Management Services Market, By Region:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

Australia

South Korea

Europe & CIS

Germany

France

United Kingdom

Spain

Italy

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Clinical Trials Management Services Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Type Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Clinical Trials Management Services Market

5. Voice of Customer

6. Global Clinical Trials Management Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service Type (Clinical Trial Monitoring, Regulatory Submissions, Clinical Trial Data Management, Site Management & Monitoring, Others)
    • 6.2.2. By Industry (Medical Devices v/s Pharmaceuticals)
    • 6.2.3. By Indication (Immunology, Hematology, Oncology, Neurology, Others)
    • 6.2.4. By Region
    • 6.2.5. By Company (2021)
  • 6.3. Market Map

7. North America Clinical Trials Management Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service Type
    • 7.2.2. By Industry
    • 7.2.3. By Indication
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Clinical Trials Management Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service Type
        • 7.3.1.2.2. By Industry
        • 7.3.1.2.3. By Indication
    • 7.3.2. Canada Clinical Trials Management Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service Type
        • 7.3.2.2.2. By Industry
        • 7.3.2.2.3. By Indication
    • 7.3.3. Mexico Clinical Trials Management Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service Type
        • 7.3.3.2.2. By Industry
        • 7.3.3.2.3. By Indication

8. Europe Clinical Trials Management Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service Type
    • 8.2.2. By Industry
    • 8.2.3. By Indication
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Clinical Trials Management Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service Type
        • 8.3.1.2.2. By Industry
        • 8.3.1.2.3. By Indication
    • 8.3.2. Germany Clinical Trials Management Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service Type
        • 8.3.2.2.2. By Industry
        • 8.3.2.2.3. By Indication
    • 8.3.3. United Kingdom Clinical Trials Management Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service Type
        • 8.3.3.2.2. By Industry
        • 8.3.3.2.3. By Indication
    • 8.3.4. Italy Clinical Trials Management Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service Type
        • 8.3.4.2.2. By Industry
        • 8.3.4.2.3. By Indication
    • 8.3.5. Spain Clinical Trials Management Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service Type
        • 8.3.5.2.2. By Industry
        • 8.3.5.2.3. By Indication

9. Asia-Pacific Clinical Trials Management Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service Type
    • 9.2.2. By Industry
    • 9.2.3. By Indication
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Clinical Trials Management Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service Type
        • 9.3.1.2.2. By Industry
        • 9.3.1.2.3. By Indication
    • 9.3.2. India Clinical Trials Management Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service Type
        • 9.3.2.2.2. By Industry
        • 9.3.2.2.3. By Indication
    • 9.3.3. Japan Clinical Trials Management Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service Type
        • 9.3.3.2.2. By Industry
        • 9.3.3.2.3. By Indication
    • 9.3.4. South Korea Clinical Trials Management Services Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Service Type
        • 9.3.4.2.2. By Industry
        • 9.3.4.2.3. By Indication
    • 9.3.5. Australia Clinical Trials Management Services Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Service Type
        • 9.3.5.2.2. By Industry
        • 9.3.5.2.3. By Indication

10. South America Clinical Trials Management Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service Type
    • 10.2.2. By Industry
    • 10.2.3. By Indication
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Clinical Trials Management Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service Type
        • 10.3.1.2.2. By Industry
        • 10.3.1.2.3. By Indication
    • 10.3.2. Argentina Clinical Trials Management Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service Type
        • 10.3.2.2.2. By Industry
        • 10.3.2.2.3. By Indication
    • 10.3.3. Colombia Clinical Trials Management Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service Type
        • 10.3.3.2.2. By Industry
        • 10.3.3.2.3. By Indication

11. Middle East and Africa Clinical Trials Management Services Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Service Type
    • 11.2.2. By Industry
    • 11.2.3. By Indication
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Clinical Trials Management Services Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Service Type
        • 11.3.1.2.2. By Industry
        • 11.3.1.2.3. By Indication
    • 11.3.2. Saudi Arabia Clinical Trials Management Services Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Service Type
        • 11.3.2.2.2. By Industry
        • 11.3.2.2.3. By Indication
    • 11.3.3. UAE Clinical Trials Management Services Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Service Type
        • 11.3.3.2.2. By Industry
        • 11.3.3.2.3. By Indication

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Laboratory Corporation of America Holdings
  • 14.2. SGS Health Sciences
  • 14.3. IQVIA, Inc.
  • 14.4. Syneous Health, Inc.
  • 14.5. Atlantic Research Group
  • 14.6. ICON PLC
  • 14.7. Charles River Laboratories International, Inc.
  • 14.8. Medpace Holdings, Inc.

15. Strategic Recommendations